Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2005
05/25/2005CN1620300A Method of administering bisphosphonates
05/25/2005CN1620299A Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
05/25/2005CN1620298A Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
05/25/2005CN1620297A 止痒剂 Antipruritic
05/25/2005CN1620296A Substituted quinazoline derivatives as inhibitors of aurora kinases
05/25/2005CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use
05/25/2005CN1620293A Polymorphs of clopidogrel hydrogensulfate
05/25/2005CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
05/25/2005CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors
05/25/2005CN1620290A Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/25/2005CN1620289A Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
05/25/2005CN1620288A Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders
05/25/2005CN1620287A Composition for pharmaceutical or dietetic use for combating hair loss
05/25/2005CN1620286A Compounds for blocking androgen receptors
05/25/2005CN1620284A Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tool for producing it
05/25/2005CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients
05/25/2005CN1620281A Formulation & dosage form for the controlled delivery of therapeutic agents
05/25/2005CN1620257A Matrix-forming composition containing pectin
05/25/2005CN1619312A Specific markers for metabolic syndrome
05/25/2005CN1618869A Polysaccharide of basidium and its use
05/25/2005CN1618796A 4, 5-disubstituted-2-(1-substituted-1 H-pyrrole-2-radical)-thiazole derivative
05/25/2005CN1618790A New Optical active derivative of flavo acidamide, its preparation method and its medicinal composition and use
05/25/2005CN1618789A Macrocyclic peptides active against the hepatitis C virus
05/25/2005CN1618434A Biological polysaccharide micro-capsule, prepn. method and application thereof
05/25/2005CN1618433A Medicine prepared with inosine and fructose composition
05/25/2005CN1618432A Complement inhibitor
05/25/2005CN1618431A Dispersion tablet contg. Gynostemma petaphylla total glucosides, and its prepn. method
05/25/2005CN1618430A Adefovir composite medicine for treating hepatitis B
05/25/2005CN1618429A Slow-release double-layer tablet for treating and preventing apoplexy, and its prepn. method
05/25/2005CN1618428A Cefadroxil oral disintegrant tablet, and its prepn. method
05/25/2005CN1618427A Medicinal resin biological adhering slow-releasing liquid prepn. contg. aciclovir, and its prepn. method
05/25/2005CN1618426A Medicinal composition contg. katopril, and its prepn. method
05/25/2005CN1618425A Composition contg. theaflavin and its derivatives, prepn. method and application thereof
05/25/2005CN1618424A Single particle nano-garlicin micro-capsule, and its prepn. method
05/25/2005CN1203184C Process for preparation of pseudomonic acid A antibiotic by microbiological method
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203177C Tumor antigen proteins, genes thereof and tumor antigen peptides
05/25/2005CN1203089C New compound
05/25/2005CN1203084C Novel crystalline forms of macrolide antibiotic
05/25/2005CN1203083C Rhizoma anemarrhenae extract and preparation process
05/25/2005CN1203074C Pentacycle taxane compounds
05/25/2005CN1203072C Pyranoindoles for treating alaucoma
05/25/2005CN1203071C Polysaccharidic esters of N-derivatives of glutamic acid
05/25/2005CN1203070C Thrombin receptor antagonists
05/25/2005CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203061C Substituted isoquinolines, its preparing process, medical composition and its use for preparing medicine
05/25/2005CN1203060C Pyridine derivatives, its composition and use
05/25/2005CN1203059C Novel processes for preparing torsemide intermediate
05/25/2005CN1203055C Method and composition for treating or preventing bacterial infection
05/25/2005CN1203049C Rapid-dissolved ambroxol salt and preparing method thereof
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/25/2005CN1202865C Synergistic combination
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/25/2005CN1202857C Medicinal pill for treating gastritis and its producing process
05/25/2005CN1202848C Chinese herbal medicine for curing periodontitis and gingivitis and preparing process thereof
05/25/2005CN1202846C Process for preparing medicine for dredging meridian and reducing blood fat
05/25/2005CN1202835C Composition for prevention of hepatic steatosis
05/25/2005CN1202834C Application of effective part of Chinese medicinal material lindley eupatorium herb in preparing antiviral medicine
05/25/2005CN1202833C Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
05/25/2005CN1202832C High-activity ginkgo leaf extract preparation and application
05/25/2005CN1202831C Macrolide formulations for inhalation and use thereof
05/25/2005CN1202830C Use of Rhizoma dioscoreae nipponicae and its dioscorea saponin treating chronic glomerulus nephritis
05/25/2005CN1202829C Pharmaceutical formulations
05/25/2005CN1202828C Use of diphosphonic acid in preparing medicine for treatment of vasculogenesis
05/25/2005CN1202827C 皮肤搽剂 Skin liniments
05/25/2005CN1202826C Neuropathy remedies
05/25/2005CN1202825C Difenidol hydrochloride oral disintegrating tablet and prparation process thereof
05/25/2005CN1202824C Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for preparing medicine for treating hepatitis virus infection
05/25/2005CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack
05/25/2005CN1202822C Nimodipine slow release capsule and its preparation method
05/25/2005CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack
05/25/2005CN1202820C Subprostrate sophora oral preparation, preparing method and use
05/25/2005CN1202819C Intraocular pressure reducing agent
05/25/2005CN1202818C Method for producing extract from cannabis plant matter, containing tetrahydrocannabinol, cannabidiol and cannabis extracts
05/25/2005CN1202817C Solid disperser of quick-releasing vitamine A acid
05/25/2005CN1202816C Glimepiride dripping pills
05/25/2005CN1202815C Delayed-action form of administration containing tramadol saccharinate
05/25/2005CN1202814C Controlled releasing Qumaduo preparation having stably releasing mode and preparing method thereof
05/25/2005CN1202812C Direct compression polymer tablet core
05/25/2005CN1202735C Pet for copmosition
05/25/2005CN1202733C Food and process for manufacturing same
05/24/2005US6897348 Comprises chitosans, niacinamide, and ascorbic acid; antibiotic-free
05/24/2005US6897340 Processes for preparation of polymorphic form II of sertraline hydrochloride
05/24/2005US6897321 Process for preparing azacycloalkanoylaminothiazoles (LD 137e)
05/24/2005US6897319 Therapeutic drugs for treating central nervous system disorders
05/24/2005US6897318 Process for making substituted pyrazoles
05/24/2005US6897317 For therapy of arteriosclerosis and dyslipidaemias
05/24/2005US6897316 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents
05/24/2005US6897315 Method for producing 8-methoxy-quinolinecarboxylic acids
05/24/2005US6897310 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction
05/24/2005US6897309 One pot process; using base; then hydroxylation
05/24/2005US6897298 Method for extracting a compound from a ginseng spp. plant, ginseng or pseudo-ginseng
05/24/2005US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2005US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases
05/24/2005US6897243 Fructosamine oxidase: antagonists and inhibitors
05/24/2005US6897242 Non-racemic mixtures of d- and l- methadone and method of treating pain
05/24/2005US6897241 Comprises N-methyl d-aspartate (NMDA) receptor antagonists such as ketamine and dextromethorphan, anticholinergic agents, and sympathetic blocking agents in a cream base
05/24/2005US6897239 New use of existing pharmaceutical misoprostol antiulcer agent, has a strong local vasodilation effect on applied tissue; a synergic action with combining alprostadil
05/24/2005US6897238 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris
1 ... 4681 4682 4683 4684 4685 4686 4687 4688 4689 4690 4691 4692 4693 4694 4695 4696 4697 4698 4699 4700 4701 ... 7860